Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks.

Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks.

Inflamm Bowel Dis. 2019 Nov 26;:

Authors: Chateau T, Peyrin-Biroulet L

PMID: 31769497 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31769497?dopt=Abstract